Author

D. Voeller

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell signaling & trafficking· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:metabolism & bioenergetics· 1 Assay:metabolomics· 1

Frequent Co-Authors

S. Lipkowitz· 3 shared C. Annunziata· 2 shared D. Meerzaman· 2 shared Q. Chen· 2 shared S. F. Gilbert· 2 shared S. Ratnayake· 2 shared Y. E. Greer· 2 shared A. Catalano· 1 shared

Activity by Year

2022-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

S. Lipkowitz

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

TRAIL-induced cytokine production via NFKB2 pathway promotes neutrophil chemotaxis and immune suppression in triple negative breast cancers

M. Kundu, Y. E. Greer, A. Lobanov, L. Ridnour, R. N. Donahue, Y. Ng, S. Ratnayake, D. Voeller, S. Weltz, Q. Chen, S. J. Lockett, M. Cam, D. Meerzaman, D. A. Wink, S. Lipkowitz

This study shows TRAIL treatment of TNBC cells activates the NFKB2 pathway, leading to cytokine production that enhances neutrophil chemotaxis and immune suppression.

bioRxiv · Jul 19, 2024 · PreprintCancer Biology

Mitochondrial Matrix Protease ClpP Agonists inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis

Y. E. Greer, L. Hernandez, E. M. J. Fennell, D. Voeller, R. Chari, S. F. Gilbert, B. Tang, M. Hafner, C. Annunziata, E. Iwanowicz, L. M. Graves, S. Lipkowitz

This study shows that ClpP agonists inhibit breast cancer stem cell function by disrupting mitochondrial homeostasis and multiple metabolic pathways.

bioRxiv · Mar 18, 2022Cancer Biology

Flotillin-2 regulates EGFR activation, degradation, and cancer growth

D. J. Wisniewski, M. S. Liyasova, S. Korrapati, X. Zhang, S. Ratnayake, Q. Chen, S. F. Gilbert, A. Catalano, D. Voeller, D. Meerzaman, U. J. Guha, N. Porat-Shliom, C. Annunziata, S. Lipkowitz

This study shows that Flotillin-2 negatively regulates EGFR activation, ubiquitination, trafficking, and degradation, thereby suppressing cancer growth.

bioRxiv · Mar 11, 2022 · PreprintCancer Biology